title: Allogeneic bone marrow transplant for multiple myeloma.
authors.forename: N H
authors.initials: NH
authors.lastname: Russell
authors.forename: G
authors.initials: G
authors.lastname: Miflin
authors.forename: C
authors.initials: C
authors.lastname: Stainer
authors.forename: J G
authors.initials: JG
authors.lastname: McQuaker
authors.forename: N
authors.initials: N
authors.lastname: Bienz
authors.forename: A P
authors.initials: AP
authors.lastname: Haynes
authors.forename: E M
authors.initials: EM
authors.lastname: Bessell
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D008297:Male; D008558:Melphalan; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*; D019172:Transplantation Conditioning; D016896:Treatment Outcome; D014916:Whole-Body Irradiation
chemical_list: D000970:Antineoplastic Agents; D008558:Melphalan